Daiwa Securities Group Inc. - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 125 filers reported holding IMMUNOVANT INC in Q1 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$20
+100.0%
5200.0%0.00%
Q2 2023$10
+25.0%
5200.0%0.00%
Q1 2023$8
-11.1%
5200.0%0.00%
Q4 2022$9
-99.6%
520
+32.0%
0.00%
Q3 2022$2,0000.0%3940.0%0.00%
Q2 2022$2,0000.0%3940.0%0.00%
Q1 2022$2,000
-33.3%
3940.0%0.00%
Q4 2021$3,0000.0%3940.0%0.00%
Q3 2021$3,000
+50.0%
394
+114.1%
0.00%
Q2 2021$2,000
-33.3%
1840.0%0.00%
Q1 2021$3,000
-62.5%
1840.0%0.00%
Q4 2020$8,0001840.00%
Other shareholders
IMMUNOVANT INC shareholders Q1 2021
NameSharesValueWeighting ↓
Alpine Global Management, LLC 3,007,000$25,620,0003.77%
Deep Track Capital, LP 4,775,000$40,683,0002.87%
Octagon Capital Advisors LP 572,862$4,881,0000.95%
Eventide Asset Management 4,950,000$42,174,0000.54%
WITTENBERG INVESTMENT MANAGEMENT, INC. 140,500$1,197,0000.44%
FRAZIER MANAGEMENT LLC 585,759$4,991,0000.38%
MANGROVE PARTNERS IM, LLC 688,000$5,862,0000.35%
BCK CAPITAL MANAGEMENT LP 54,293$463,0000.31%
EcoR1 Capital, LLC 1,140,819$9,720,0000.31%
MANGROVE PARTNERS IM, LLC 570,400$4,860,0000.29%
View complete list of IMMUNOVANT INC shareholders